EA200701156A1 - Гидрохлорид дигидрат (s)-(-)-1-(4-фторизохинолин-5-ил)сульфонил-2-метил-1,4-гомопиперазина - Google Patents

Гидрохлорид дигидрат (s)-(-)-1-(4-фторизохинолин-5-ил)сульфонил-2-метил-1,4-гомопиперазина

Info

Publication number
EA200701156A1
EA200701156A1 EA200701156A EA200701156A EA200701156A1 EA 200701156 A1 EA200701156 A1 EA 200701156A1 EA 200701156 A EA200701156 A EA 200701156A EA 200701156 A EA200701156 A EA 200701156A EA 200701156 A1 EA200701156 A1 EA 200701156A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methyl
dihydrate
homopiperasine
fluorosohinolin
sulfonil
Prior art date
Application number
EA200701156A
Other languages
English (en)
Other versions
EA011283B1 (ru
Inventor
Такеси Охсима
Хироеси Хидака
Масами Сирацути
Казухиро Оноги
Тосиаки Ода
Original Assignee
Кова Ко., Лтд.
Д. Вестерн Терапьютикс Инститьют, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36498130&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200701156(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Кова Ко., Лтд., Д. Вестерн Терапьютикс Инститьют, Инк. filed Critical Кова Ко., Лтд.
Publication of EA200701156A1 publication Critical patent/EA200701156A1/ru
Publication of EA011283B1 publication Critical patent/EA011283B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Данное изобретение относится к гидрохлорид дигидрату (S)-(-)-1-(4-фторизохинолин-5-ил)сульфонил-2-метил-1,4-гомопиперазина, к способу получения дигидрата и к композиции лекарственного средства, содержащего дигидрат. Соединение данного изобретения обладает меньшей гигроскопичностью по сравнению с безводными кристаллами гидрохлорида (S)-(-)-1-(4-фторизохинолин-5-ил)сульфонил-2-метил-1,4-гомопиперазина и, таким образом, проявляет отличную химическую стабильность.
EA200701156A 2004-11-29 2005-11-29 Гидрохлорид дигидрат (s)-(-)-1-(4-фторизохинолин-5-ил)сульфонил-2-метил-1,4-гомопиперазина EA011283B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004344271 2004-11-29
PCT/JP2005/021844 WO2006057397A1 (ja) 2004-11-29 2005-11-29 （ｓ）－（－）－１－（４－フルオロイソキノリン－５－イル）スルホニル－２－メチル－１，４－ホモピペラジン塩酸塩・二水和物

Publications (2)

Publication Number Publication Date
EA200701156A1 true EA200701156A1 (ru) 2007-10-26
EA011283B1 EA011283B1 (ru) 2009-02-27

Family

ID=36498130

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200701156A EA011283B1 (ru) 2004-11-29 2005-11-29 Гидрохлорид дигидрат (s)-(-)-1-(4-фторизохинолин-5-ил)сульфонил-2-метил-1,4-гомопиперазина

Country Status (24)

Country Link
US (1) US7858615B2 (ru)
EP (1) EP1818329B1 (ru)
JP (1) JP4016060B2 (ru)
KR (1) KR101253369B1 (ru)
CN (1) CN101068806B (ru)
AT (1) ATE465159T1 (ru)
AU (1) AU2005308060B2 (ru)
BR (1) BRPI0517909B8 (ru)
CA (1) CA2589237C (ru)
CY (1) CY1112406T1 (ru)
DE (1) DE602005020835D1 (ru)
DK (1) DK1818329T3 (ru)
EA (1) EA011283B1 (ru)
ES (1) ES2345562T3 (ru)
HK (1) HK1112898A1 (ru)
MX (1) MX2007006322A (ru)
MY (1) MY139797A (ru)
NO (1) NO339021B1 (ru)
NZ (1) NZ555560A (ru)
PL (1) PL1818329T3 (ru)
PT (1) PT1818329E (ru)
TW (1) TWI354670B (ru)
WO (1) WO2006057397A1 (ru)
ZA (1) ZA200704201B (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006290827A (ja) * 2005-04-13 2006-10-26 Kowa Co 緑内障予防又は治療剤
AU2006285915B2 (en) 2005-08-30 2011-02-24 Asahi Kasei Pharma Corporation Sulfonamide compound
US8415372B2 (en) * 2007-02-27 2013-04-09 Asahi Kasei Pharma Corporation Sulfonamide compound
WO2008105442A1 (ja) * 2007-02-28 2008-09-04 Asahi Kasei Pharma Corporation スルホンアミド誘導体
WO2009004792A1 (ja) 2007-07-02 2009-01-08 Asahi Kasei Pharma Corporation スルホンアミド化合物及びその結晶
UA102128C2 (en) * 2008-12-05 2013-06-10 Х. Луннбек А/С Nalmefene hydrochloride dihydrate
EP2610252A4 (en) 2010-08-26 2013-09-04 Kowa Co NOVEL PROCESS FOR THE PRODUCTION OF ISOQUINOLINE DERIVATIVES AND THEIR SALTS
KR102177199B1 (ko) * 2013-04-24 2020-11-10 고쿠리쓰다이가쿠호진 규슈다이가쿠 안저질환 치료제
TWI671071B (zh) * 2014-09-25 2019-09-11 日商興和股份有限公司 醫藥製劑
US10369781B2 (en) * 2015-01-08 2019-08-06 Hewlett-Packard Development Company, L.P. Mobile printers
CN107216311B (zh) * 2016-03-21 2019-09-03 山东诚创医药技术开发有限公司 (s)-4-[(4-氟代异喹啉-5-基)磺酰基]-3-甲基-1,4-二氮杂环庚烷盐酸盐的精制方法
CN106496189A (zh) * 2016-10-10 2017-03-15 江苏礼华生物技术有限公司 盐酸Ripasudil晶型
CN107164328A (zh) * 2017-06-30 2017-09-15 太仓卡斯特姆新材料有限公司 一种高稳定性mcf‑7乳腺癌细胞的复苏方法
JP7425482B2 (ja) 2018-12-17 2024-01-31 株式会社デ・ウエスタン・セラピテクス研究所 イソキノリンスルホンアミドの新規な形態
WO2020253882A1 (zh) 2019-06-21 2020-12-24 中山大学中山眼科中心 作为rock蛋白激酶抑制剂的异喹啉酮的衍生物及其应用
CN114644618A (zh) 2020-12-21 2022-06-21 广州润尔眼科生物科技有限公司 一种作为rock蛋白激酶抑制剂的异喹啉酮型化合物的盐型及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3734531B2 (ja) 1995-06-29 2006-01-11 旭化成ファーマ株式会社 １−（５−イソキノリンスルホニル）ホモピペラジン塩酸塩３水和物
CN1080721C (zh) * 1995-07-03 2002-03-13 旭化成株式会社 1－(5－异喹啉磺酰基)高哌嗪盐酸盐水合物
KR19990082174A (ko) * 1996-02-02 1999-11-25 니뽄 신야쿠 가부시키가이샤 이소퀴놀린 유도체 및 의약
JP4316794B2 (ja) * 1997-10-22 2009-08-19 株式会社デ・ウエスタン・セラピテクス研究所 イソキノリン誘導体及び医薬

Also Published As

Publication number Publication date
AU2005308060B2 (en) 2011-02-17
JPWO2006057397A1 (ja) 2008-06-05
US7858615B2 (en) 2010-12-28
PT1818329E (pt) 2010-06-22
EP1818329A1 (en) 2007-08-15
ES2345562T3 (es) 2010-09-27
CN101068806A (zh) 2007-11-07
KR20070084127A (ko) 2007-08-24
NZ555560A (en) 2008-10-31
BRPI0517909A (pt) 2008-10-21
ATE465159T1 (de) 2010-05-15
MX2007006322A (es) 2007-06-19
US20080021018A1 (en) 2008-01-24
DE602005020835D1 (de) 2010-06-02
WO2006057397A1 (ja) 2006-06-01
NO20072382L (no) 2007-08-23
EA011283B1 (ru) 2009-02-27
JP4016060B2 (ja) 2007-12-05
MY139797A (en) 2009-10-30
CA2589237C (en) 2013-05-14
PL1818329T3 (pl) 2010-10-29
KR101253369B1 (ko) 2013-04-11
BRPI0517909B1 (pt) 2018-11-21
CA2589237A1 (en) 2006-06-01
ZA200704201B (en) 2008-09-25
TWI354670B (en) 2011-12-21
CN101068806B (zh) 2012-02-01
HK1112898A1 (ru) 2008-09-19
TW200630359A (en) 2006-09-01
EP1818329A4 (en) 2009-08-05
BRPI0517909B8 (pt) 2021-05-25
NO339021B1 (no) 2016-11-07
AU2005308060A1 (en) 2006-06-01
EP1818329B1 (en) 2010-04-21
DK1818329T3 (da) 2010-07-19
CY1112406T1 (el) 2015-12-09

Similar Documents

Publication Publication Date Title
ATE465159T1 (de) (s)-(-)-1-(4-fluorisochinolin-5-yl)sulfonyl-2- methyl-1,4-homopiperazinhydrochlorid- dihydrat
EA200801608A1 (ru) Производные бензимидазолонкарбоновой кислоты
CY1107846T1 (el) Παραγωγα κιναζολινονης χρησιμα ως βανιλλοειδεις ανταγωνιστες
EA200500203A1 (ru) Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат
EA200702670A1 (ru) Препарат тиенопиридинового ингибитора агрегации тромбоцитов
MX2007003108A (es) Compuestos imidazo-3-il-amina sustituidos y biciclicos.
ATE553077T1 (de) Peptidaseinhibitoren
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
DK1628685T3 (da) Antivirale phosphonatanaloge
EA200600317A1 (ru) Производные омега-карбоксиарилдифенилмочевины (варианты), фармацевтическая композиция (варианты) и способ лечения и предупреждения заболеваний и состояний с их использованием (варианты)
CY1109568T1 (el) Ενωσεις βενζο(d)ισοξαζολ-3-υλαμινης και η χρησιμοποιηση τους σαν προσδεματα υποδοχεα βανιλλοειδων
DK1585739T3 (da) Substituerede arylcyclopropylacetamider som glucokinaseaktivatorer
TW200626610A (en) Analogs of 17-hydroxywortmannin as PI3K inhibitors
DE502005008057D1 (de) Substituierte cyclopenten-verbindungen
DK1613304T3 (da) DPP-IV-inhibitorer
NO20082116L (no) Kjemisk fremgangsmate for fremstilling av en amido-fenoksybenzosyreforbindelse
ATE495158T1 (de) Substituierte tetrahydroisochinoline als mmp- inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament
EA200600551A1 (ru) Соединения пиперазина, способ их получения и фармацевтические композиции, которые их содержат
WO2006100026A8 (de) 2-oxo-1,2,4,5-tetrahydro-1,3-benzdiazepin-3-yl-piperidine als cgrp-antagonisten
DK1529043T3 (da) Fremgangsmåde til fremstilling af 2-methylpiperazin-derivater
SE0403003D0 (sv) Chemical compound 1
TH79612B (th) (s)-(-)-1-(4-ฟลูออโรไอโซควินอลิน-5-อิล๗ ซัลโฟนิล-2-เมธิล-1,4-ฮอมอพิราซีนไฮโดรคลอไรด์ ไดไฮเดรท
TH79612A (th) (s)-(-)-1-(4-ฟลูออโรไอโซควินอลิน-5-อิล) ซัลโฟนิล-2-เมธิล-1,4-ฮอมอพิเพอราซีนไฮโดรคลอไรด์ ไดไฮเดรท
UA93030C2 (ru) Способ получения клопидогрела (варианты) и промежуточные соединения
TH79960A (th) สารประกอบ

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM